公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy | Chang C.-F.; Pao J.-B.; Yu C.-C.; CHAO-YUAN HUANG ; Huang S.-P.; Yang Y.-P.; Huang C.-N.; Chang T.-Y.; You B.-J.; Lee H.-Z.; Hour T.-C.; Bao B.-Y. | Annals of Surgical Oncology | 16 | 15 | |
2012 | Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU ; Hsieh C.-J.; Bao B.-Y. | Annals of Oncology | 42 | 39 | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2012 | Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy | Huang S.-P.; Bao B.-Y.; Hour T.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Liu C.-C.; Lee Y.-C.; Huang C.-N.; Pao J.-B.; Huang C.-H. | PLoS ONE | 16 | 29 | |
2016 | Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival | Bao B.-Y.; Lin V.C.; Yu C.-C.; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Lee H.-Z.; Pao J.-B.; CHAO-YUAN HUANG ; Huang S.-P. | Scientific Reports | 18 | 19 | |
2011 | Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. | Clinical Cancer Research | 64 | 56 | |
2016 | Prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy | Lee C.-H.; Pao J.-B.; Lu T.-L.; Lee H.-Z.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Lin V.C.; Yu C.-C.; Yin H.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Medical Sciences | 5 | 2 | |
2012 | Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Chen L.-M.; Ting W.-C.; Hsieh C.-J.; Huang S.-P. | International Journal of Cancer | 21 | 19 | |
2013 | Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer | Pao J.-B.; Yang Y.-P.; Huang C.-N.; Huang S.-P.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; CHAO-YUAN HUANG ; Bao B.-Y. | World Journal of Urology | 11 | 10 |